Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,058,844
+$1,840,643 QoQ
Shares Held
1,058,424
+39.9% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. MGNX ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in MGNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,058,844 | 1,058,424 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,218,201 | 756,647 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $373,296 | 222,200 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $121,618 | 100,511 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $36,449 | 28,700 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $391,605 | 119,029 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $484,755 | 114,060 | Shares | Defined | 2024-08-14 | |
| 2023-06-30 | $485,368 | 90,723 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,086,649 | 151,555 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,314,250 | 493,927 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,008,713 | 580,553 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,494,676 | 845,653 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,119,668 | 240,598 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $953,289 | 59,395 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,648,229 | 78,712 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,428,517 | 127,644 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,542,981 | 362,417 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,970,855 | 567,404 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,375,198 | 729,464 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $23,861,883 | 854,652 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,388,248 | 410,352 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||